These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16649726)

  • 1. Assessment of markers of thrombin generation in patients with acute myocardial infarction complicated by ventricular fibrillation.
    Elmas E; Kaelsch T; Wolpert C; Sueselbeck T; Bertsch T; Dempfle CE; Borggrefe M
    Clin Cardiol; 2006 Apr; 29(4):165-9. PubMed ID: 16649726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of elevated hemostatic markers in patients with acute myocardial infarction.
    Li YH; Teng JK; Tsai WC; Tsai LM; Lin LJ; Guo HR; Chen JH
    J Am Coll Cardiol; 1999 May; 33(6):1543-8. PubMed ID: 10334421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
    Granger CB; Becker R; Tracy RP; Califf RM; Topol EJ; Pieper KS; Ross AM; Roth S; Lambrew C; Bovill EG
    J Am Coll Cardiol; 1998 Mar; 31(3):497-505. PubMed ID: 9502626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin activity throughout the acute phase of acute ST-elevation myocardial infarction and the relation to outcome.
    Ulrich-Möckel NV; Riehle M; Vollert J; Heller G; Störk T; Riess H; Müller C; Frei U; Möckel M
    Biomarkers; 2009 Aug; 14(5):311-6. PubMed ID: 19552570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent thrombin generation during heparin therapy in patients with acute coronary syndromes.
    Merlini PA; Ardissino D; Bauer KA; Oltrona L; Pezzano A; Bottasso B; Rosenberg RD; Mannucci PM
    Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1325-30. PubMed ID: 9261263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of markers of thrombin generation in the acute and chronic phases of non cardioembolic ischemic stroke.
    Soncini M; Gasparini P; Lorena M; Motta A; Cimminiello C
    Minerva Cardioangiol; 2000 Nov; 48(11):349-56. PubMed ID: 11214426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High plasma levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and interleukin-8 (IL-8) characterize patients prone to ventricular fibrillation complicating myocardial infarction.
    Elmas E; Lang S; Dempfle CE; Kälsch T; Hannak D; Sueselbeck T; Wolpert C; Borggrefe M; Brueckmann M
    Clin Chem Lab Med; 2007; 45(10):1360-5. PubMed ID: 17727318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of low-dose heparin on fibrinogen levels in patients with chronic ischemic heart disease.
    Prisco D; Paniccia R; Bandinelli B; Gori AM; Attanasio M; Giusti B; Comeglio M; Abbate R; Gensini GF; Serneri GG
    Int J Clin Lab Res; 1998; 28(3):170-3. PubMed ID: 9801927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between plasmin activation system and intravascular ultrasound signs of plaque instability in patients with unstable angina and non-st-segment elevation myocardial infarction.
    Gyöngyösi M; Glogar D; Weidinger F; Domanovits H; Laggner A; Wojta J; Zorn G; Iordanova N; Huber K
    Am Heart J; 2004 Jan; 147(1):158-64. PubMed ID: 14691435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock.
    Gando S; Nanzaki S; Sasaki S; Aoi K; Kemmotsu O
    Crit Care Med; 1998 Dec; 26(12):2005-9. PubMed ID: 9875912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. TIMI-5 Investigators. Thrombolysis in Myocardial Infarction.
    Scharfstein JS; Abendschein DR; Eisenberg PR; George D; Cannon CP; Becker RC; Sobel B; Cupples LA; Braunwald E; Loscalzo J
    Am J Cardiol; 1996 Sep; 78(5):503-10. PubMed ID: 8806332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothrombin fragments F1+2, thrombin-antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis.
    Giannitsis E; Siemens HJ; Mitusch R; Tettenborn I; Wiegand U; Schmücker G; Sheikhzadeh A; Stierle U
    Int J Cardiol; 1999 Mar; 68(3):269-74. PubMed ID: 10213277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic antithrombin III administration during pregnancy immediately reduces the thrombin hyperactivity of congenital antithrombin III deficiency by forming thrombin-antithrombin III complexes.
    Kario K; Matsuo T; Kodama K; Matsuo M
    Thromb Res; 1992 Jun; 66(5):509-15. PubMed ID: 1523607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM Trial.
    Christersson C; Oldgren J; Bylock A; Siegbahn A; Wallentin L
    Eur Heart J; 2007 Mar; 28(6):692-8. PubMed ID: 17314111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent generation of thrombin after acute myocardial infarction.
    Szczeklik A; Dropinski J; Radwan J; Krzanowski M
    Arterioscler Thromb; 1992 May; 12(5):548-53. PubMed ID: 1576116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction.
    Merlini PA; Bauer KA; Oltrona L; Ardissino D; Cattaneo M; Belli C; Mannucci PM; Rosenberg RD
    Circulation; 1994 Jul; 90(1):61-8. PubMed ID: 8026047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of heparin-resistant thrombin activity with acute ischemic complications of coronary interventions.
    Oltrona L; Eisenberg PR; Lasala JM; Sewall DJ; Shelton ME; Winters KJ
    Circulation; 1996 Nov; 94(9):2064-71. PubMed ID: 8901652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.